
1. Rotunda AM, et al. Injectable treatments for localized adiposity: deoxycholate and phosphatidylcholine. *Dermatol Surg*. 2005;31(11 Pt 1):1637–1646. doi:10.1097/00042728-200511000-00018
2. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. *Aesthetic Plast Surg*. 2001;25(5):362–365. doi:10.1007/s002660010141
3. Ascher B, et al. ATX-101 (deoxycholic acid injection) for reduction of submental fat: results from a phase III clinical trial. *Br J Dermatol*. 2014;170(2):445–453. doi:10.1111/bjd.12624
4. Walker P, et al. ATX-101 for reduction of unwanted submental fat: results of a randomized trial. *Clin Cosmet Investig Dermatol*. 2014;7:307–316. doi:10.2147/CCID.S67406
5. Duncan DI, Rotunda AM. Injectable therapies for subcutaneous fat: a review. *Aesthet Surg J*. 2011;31(1):86–98. doi:10.1177/1090820X10387945
6. Schuller-Petrovic S, et al. Lipolysis of human adipose tissue by deoxycholate. *J Dermatol Sci*. 2008;50(3):173–178. doi:10.1016/j.jdermsci.2007.12.008
7. Bechara FG, et al. Side effects and complications of injections with phosphatidylcholine and deoxycholate. *Dermatol Surg*. 2006;32(8):980–988. doi:10.1111/j.1524-4725.2006.32199.x
8. Kythera Biopharmaceuticals. Kybella (deoxycholic acid) injection prescribing information. FDA label. 2015.
9. Matarasso SL, Pfeifer TM. Mesotherapy and injection lipolysis. *Clin Plast Surg*. 2008;35(4):513–527. doi:10.1016/j.cps.2008.05.007
10. Reeds DN, et al. Deoxycholic acid injection for localized fat reduction: mechanism and efficacy. *Obesity (Silver Spring)*. 2013;21(2):E455–E462. doi:10.1002/oby.20178
2. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. *Aesthetic Plast Surg*. 2001;25(5):362–365. doi:10.1007/s002660010141
3. Ascher B, et al. ATX-101 (deoxycholic acid injection) for reduction of submental fat: results from a phase III clinical trial. *Br J Dermatol*. 2014;170(2):445–453. doi:10.1111/bjd.12624
4. Walker P, et al. ATX-101 for reduction of unwanted submental fat: results of a randomized trial. *Clin Cosmet Investig Dermatol*. 2014;7:307–316. doi:10.2147/CCID.S67406
5. Duncan DI, Rotunda AM. Injectable therapies for subcutaneous fat: a review. *Aesthet Surg J*. 2011;31(1):86–98. doi:10.1177/1090820X10387945
6. Schuller-Petrovic S, et al. Lipolysis of human adipose tissue by deoxycholate. *J Dermatol Sci*. 2008;50(3):173–178. doi:10.1016/j.jdermsci.2007.12.008
7. Bechara FG, et al. Side effects and complications of injections with phosphatidylcholine and deoxycholate. *Dermatol Surg*. 2006;32(8):980–988. doi:10.1111/j.1524-4725.2006.32199.x
8. Kythera Biopharmaceuticals. Kybella (deoxycholic acid) injection prescribing information. FDA label. 2015.
9. Matarasso SL, Pfeifer TM. Mesotherapy and injection lipolysis. *Clin Plast Surg*. 2008;35(4):513–527. doi:10.1016/j.cps.2008.05.007
10. Reeds DN, et al. Deoxycholic acid injection for localized fat reduction: mechanism and efficacy. *Obesity (Silver Spring)*. 2013;21(2):E455–E462. doi:10.1002/oby.20178